P/E ratio for Alkem Laboratories (ALKEM.NS)
P/E ratio as of April 2024 (TTM): 47.9
According to Alkem Laboratories 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 47.8613. At the end of 2022 the company had a P/E ratio of 35.2.
P/E ratio history for Alkem Laboratories from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 35.2 | 44.42% |
| 2021 | 24.4 | 6.83% |
| 2020 | 22.8 | 4.75% |
| 2019 | 21.8 | -38.31% |
| 2018 | 35.3 | -7.03% |
| 2017 | 38.0 | 64.09% |
| 2016 | 23.1 | 2.46% |
| 2015 | 22.6 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.